Elucid

Elucid

医疗设备制造业

Boston,Massachusetts 7,068 位关注者

Bringing Imaging to Life

关于我们

Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.

网站
https://elucid.com
所属行业
医疗设备制造业
规模
51-200 人
总部
Boston,Massachusetts
类型
私人持股
创立
2013
领域
cardiovascular、plaque characterization、FFRct、CCTA、Heart Disease、CT Angiography、CCT、Stroke和Heart Attck

地点

  • 主要

    399 Boylston St

    Suite 400

    US,Massachusetts,Boston,02116

    获取路线

Elucid员工

动态

相似主页

查看职位

融资

Elucid 共 9 轮

上一轮

C 轮

US$80,000,000.00

Crunchbase 上查看更多信息